2018 - The Year of the BioTechs, page-9

  1. 3,152 Posts.
    lightbulb Created with Sketch. 335
    Looking at last years Half Yearly report of Late February 2017, there was a comprehensive summary of the Cellmid operation and its constituent parts.
    I look forward to this years HY in the coming weeks where there will no doubt be some excellent news.
    Dont really expect to hear much in the interim but if the SP wants to go berserk in anticipation that fine with me.
    Last edited by Pharmargeddon: 14/02/18
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.6¢
Change
0.000(0.00%)
Mkt cap ! $2.977M
Open High Low Value Volume
0.6¢ 0.6¢ 0.6¢ $4.864K 810.6K

Buyers (Bids)

No. Vol. Price($)
3 1280000 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 300000 1
View Market Depth
Last trade - 09.59am 15/07/2025 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.